Clinical relevance of glucose patterns in older adults
Clinical relevance of glucose patterns in older adults
批准号:
10577732
负责人:
Elizabeth Selvin
金额:
$67.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-01 至 2025-02-28
关键词:
AdultAgeAtherosclerosis Risk in CommunitiesBiological MarkersCardiacCardiovascular DiseasesClinicalContinuous Glucose MonitorDataDevelopmentDiabetes MellitusDiagnosisDiseaseElderlyFrequenciesFructosamineFundingFutureGlucoseGlycosylated hemoglobin AGoalsGrantGuidelinesHealthHealth StatusHomeostasisHyperglycemiaHypoglycemiaImpaired cognitionInvestigationKidneyLaboratoriesLeadManuscriptsMeasurementMeasuresMethodsMotivationNon-Insulin-Dependent Diabetes MellitusOutcomeParticipantPatternPeripheral Nervous System DiseasesPersonsPhysical FunctionPhysiologicalPopulationPrediabetes syndromeQuality of lifeRecommendationRiskRisk FactorsSerumTechnologyTimeUncertaintyVariantVisitVulnerable PopulationsWorkblood glucose regulationclinical practiceclinically relevantcognitive functioncohortevidence basefollow-upfrailtyglycosylated serum albuminhealth related quality of lifehuman old age (65+)mortalitynon-diabeticnovelprognosticprospectiveresponsesuccessvirtual
中文摘要
摘要
葡萄糖稳态紊乱和葡萄糖不稳定在老年人中很常见。年龄是最重要的
2型糖尿病的发生发展的重要危险因素,越来越多的证据表明,
变异性导致并发症风险,与平均血糖或HbA1c无关。在老年人中,
对于糖尿病,关于适当的治疗目标存在争议,并且低血糖是主要关注点。
动态血糖监测(CGM)是评估低血糖的推荐方法,
血糖变异性,但这项技术很少用于老年人。非常老的成年人(80岁或
老年人是一个特别脆弱的群体,但很少被纳入以前的研究。我们的总体
目的是使用最先进的CGM技术表征老年人(>80岁)的葡萄糖模式。
我们将描述“正常”的血糖模式,并评估未识别的血糖变化的频率。
有糖尿病和无糖尿病的成年人(包括前驱糖尿病患者)的旅行。我们将葡萄糖
包括血糖波动(低血糖和高血糖)与当前健康状况和临床结局的模式
在4年的随访中。这些结果将提供有关血糖模式的临床相关性的信息
在老年人群中,并就使用和解释
在这个人群中,
英文摘要
Abstract
Disordered glucose homeostasis and glucose instability are common in older adults. Age is one of the most
important risk factors for the development of type 2 diabetes and there is growing evidence that glycemic
variability contributes to risk of complications, independent of average glucose or HbA1c. In older adults with
diabetes, there is controversy regarding appropriate treatment targets and hypoglycemia is a major concern.
Continuous glucose monitoring (CGM) is the recommended approach to the assessment of hypoglycemia and
glycemic variability, but this technology has rarely been used in older adults. Very old adults (age 80 years or
older) are a particularly vulnerable population but have rarely been included in prior studies. Our overarching
objective is to characterize glucose patterns in older adults (>80 years) using state-of-the-art CGM technology.
We will characterize “normal” glucose patterns and evaluate the frequency of unrecognized glycemic
excursions in adults with and without diabetes (including persons with prediabetes). We will relate glucose
patterns including glucose excursions (hypo- and hyperglycemia) to current health status and clinical outcomes
during 4 years of follow-up. These results will provide information on the clinical relevance of glucose patterns
in an older adult population and generate evidence-based guidance regarding the use and interpretation of
CGM in this population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes
-
批准号:10370439
-
项目类别:
-
资助金额:$42.6万
-
财政年份:2021
-
负责人:Elizabeth Selvin
-
依托单位:
Clinical relevance of glucose patterns in older adults
-
批准号:10361563
-
项目类别:
-
资助金额:$65.9万
-
财政年份:2021
-
负责人:Elizabeth Selvin
-
依托单位:
Effects of the DASH diet on glucose patterns in adults with type 2 diabetes
-
批准号:10611426
-
项目类别:
-
资助金额:$55.95万
-
财政年份:2021
-
负责人:Elizabeth Selvin
-
依托单位:
Glucose instability and neurocognitive outcomes in older adults
-
批准号:10295921
-
项目类别:
-
资助金额:$240.82万
-
财政年份:2021
-
负责人:Elizabeth Selvin
-
依托单位:
Clinical relevance of glucose patterns in older adults
-
批准号:10221142
-
项目类别:
-
资助金额:$75.74万
-
财政年份:2021
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes
-
批准号:10401428
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2020
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes
-
批准号:10613536
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2020
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes
-
批准号:9977473
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2020
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes
-
批准号:10165818
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2020
-
负责人:Elizabeth Selvin
-
依托单位:
Alternative Biomarkers of Hyperglycemia in ADVANCE
-
批准号:9067724
-
项目类别:
-
资助金额:$57.82万
-
财政年份:2016
-
负责人:Elizabeth Selvin
-
依托单位:
Alternative Biomarkers of Hyperglycemia in ADVANCE
-
批准号:9416112
-
项目类别:
-
资助金额:$44.44万
-
财政年份:2016
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes
-
批准号:8945373
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2015
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes
-
批准号:9108962
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2015
-
负责人:Elizabeth Selvin
-
依托单位:
Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes
-
批准号:9274261
-
项目类别:
-
资助金额:$13.14万
-
财政年份:2015
-
负责人:Elizabeth Selvin
-
依托单位:
Diabetes and Prediabetes in Older Adults in ARIC
-
批准号:9052414
-
项目类别:
-
资助金额:$77.86万
-
财政年份:2011
-
负责人:Elizabeth Selvin
-
依托单位:
Comparative Epidemiology for Emerging Glycemic Markers
-
批准号:8417018
-
项目类别:
-
资助金额:$52.69万
-
财政年份:2011
-
负责人:Elizabeth Selvin
-
依托单位:
Comparative Epidemiology for Emerging Glycemic Markers
-
批准号:8599766
-
项目类别:
-
资助金额:$59.11万
-
财政年份:2011
-
负责人:Elizabeth Selvin
-
依托单位:
Comparative Epidemiology for Emerging Glycemic Markers
-
批准号:8050235
-
项目类别:
-
资助金额:$67.85万
-
财政年份:2011
-
负责人:Elizabeth Selvin
-
依托单位:
Comparative Epidemiology for Emerging Glycemic Markers
-
批准号:8213603
-
项目类别:
-
资助金额:$56.81万
-
财政年份:2011
-
负责人:Elizabeth Selvin
-
依托单位:
Comparative Epidemiology for Emerging Glycemic Markers
-
批准号:8787105
-
项目类别:
-
资助金额:$62.45万
-
财政年份:2011
-
负责人:Elizabeth Selvin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: